Statements (70)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:neurodegenerative_diseases
|
| gptkbp:affects |
organs
|
| gptkbp:associated_with |
gptkb:Oncology
|
| gptkbp:caused_by |
light chain proteins
|
| gptkbp:complications |
heart failure
kidney damage liver dysfunction gastrointestinal issues nervous system issues |
| gptkbp:diagnosis |
gptkb:MRI
CT scan variable biopsy echocardiogram immunofixation electrophoresis serum free light chain assay |
| https://www.w3.org/2000/01/rdf-schema#label |
AL amyloidosis
|
| gptkbp:prevalence |
rare
|
| gptkbp:research |
ongoing
|
| gptkbp:research_focus |
biomarkers
clinical trials genetic factors new therapies pathophysiology |
| gptkbp:risk_factor |
age
autoimmune diseases family history certain infections chronic inflammatory conditions |
| gptkbp:symptoms |
gptkb:anemia
fatigue weight loss fever swelling confusion seizures vision problems chest pain diarrhea hearing loss joint pain constipation difficulty swallowing dry mouth arrhythmias night sweats shortness of breath numbness carpal tunnel syndrome easy bruising skin changes tingling coughing up blood thickened skin peripheral edema severe headaches swollen tongue |
| gptkbp:treatment |
palliative care
rehabilitation nutritional support supportive care chemotherapy psychosocial support targeted therapy pain management clinical management stem cell transplant antimicrobial therapy |
| gptkbp:bfsParent |
gptkb:neurodegenerative_diseases
|
| gptkbp:bfsLayer |
4
|